News & Events about Greenlight Biosciences Holding.
GreenLight is sharing its business strategy and how it can impact food security, biodiversity, health, and climate in its 2022 Sustainability Report.
BOSTON, April 12, 2023 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to ...
4 months ago
GreenLights mRNA design, formulation and manufacturing expertise is currently applied to research and develop mRNA vaccine candidates
The effort will combine GreenLights mRNA design and manufacturing expertise with EpiVaxs advanced Ancer pipeline for personalized cancer vaccine ...
7 months ago
Credit Suisse annual conference
GreenLight CEO Andrey Zarur will present to the Credit Suisse 31st Annual Healthcare Conference
BOSTON, Nov. 07, 2022 (GLOBE NEWSWIRE) -- GreenLight Biosciences (Nasdaq: GRNA), a public benefit corporation striving to deliver on the potential of RNA to address some...
8 months ago
GreenLight's plant health research team is working to develop a solution to fall armyworm
GreenLight Biosciences and Queensland University of Technology (QUT) partner to create a solution for fall armywormFall armyworm is one of the most destructive insect pests on the planet, ...
9 months ago
GreenLight human health research labs
GreenLight Biosciences Announces Second Quarter 2022 Financial Results and Highlights Recent Company Progress
GreenLight raised $108.4 million in private placement led by S2G Ventures with strong participation from existing and new investors with cash ...